Off-label Botox applications linked to deaths
-Grinza
08/17/2009 - Botox, the famous anti-wrinkle drug, has been linked to fatal and severe complications in cerebral palsy patients, a treatment unapproved by the U.S. Food and Drug Administration (FDA).
Botox and other similar products use a purified form of botulinum toxin that temporarily paralyzes the muscles to stop repetitive movements, preventing wrinkles from forming. In addition to its cosmetic applications, Botox has also been approved by the FDA to treat excessive sweating, crossed eyes, and other conditions.
However, physicians also use the drug for unapproved or ‘off-label’ procedures, which include treatments for muscle spasticity and cerebral palsy. In these procedures, high levels of Botox are injected into the bodies of cerebral palsy patients to control involuntary muscle movements and rigidity disorders.
This poses a serious health risk. Large doses of the drug can migrate to other parts of the body, like the lungs and the throat. While Botox does not pose damage to the administered part, it can interfere or stop breathing if it gets to the throat. There have been many cases, especially on child cases, wherein the patients were hospitalized or died after Botox spread through their bodies.
“The use of Botox or Myobloc for the treatment of muscle spasticity is not approved in the United States for adults or children because the efficacy and risks of the treatment have not been determined,” warns attorneyatlaw.com.
Last April, the FDA issued an order on the manufacturers to place stronger warnings on the Botox and other similar products.
If you or a loved one have been injured or suffered a loss due to Botox Side Effects you may be entitled to compensation. Contact the Botox Lawyers of Ennis & Ennis, P.A. today for a free Botox case evaluation by filling out the form on this page or calling toll-free: 1-800-856-6405.
